Latest AI and machine learning research in oncology/hematology for healthcare professionals.
OBJECTIVES: To develop a random survival forest (RSF) machine learning (ML) model for predicting venous thromboembolism (VTE) risk in rheumatoid arthritis (RA) patients initiating biological (b) or targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs) and compare its model performance with a regularized Cox regression (RegCox) model. METHODS: This retrospective cohort study using ...
BackgroundPeople living with dementia (PLWD) with advanced illness are prone to respiratory distress yet often cannot self-report dyspnea, delaying recognition and treatment. Near-field radio-frequency (NFRF) sensors offer touchless, covert cardiopulmonary monitoring that may be better tolerated than tethered devices.ObjectivesTo assess the feasibility and acceptability of NFRF bed sensor for home...
To evaluate the diagnostic proficiency of well-established multimodal Large Language Models (LLMs)-specifically Gemini, Claude, and Copilot-in interpr...
This invited commentary grew out of a presentation made at the 2025 ConRad Meeting in Munich, Germany, and summarizes talks made by researchers suppor...
Positron emission tomography (PET) has been used in pediatric oncology since the modality gained traction 20 years ago but has been used more sparingl...
OBJECTIVES: To investigate mammographic features associated with high artificial intelligence (AI) risk scores as provided by two AI models applied to...
Uveal melanoma (UVM) is an aggressive intraocular malignancy with a high risk of metastasis but few effective therapies. However, current molecular cl...
Molecular testing can refine the prediction of cancer recurrence. We sought to compare patterns of gene expression in patients with and without recurr...
Multicellular programs in the tumour microenvironment (TME) drive cancer pathogenesis and response to therapy but remain challenging to identify and p...
The high cost and attrition rate of drug development underscore the need for more effective strategies for therapeutic target discovery. Here, we pres...
Human T-lymphotropic virus type 1 (HTLV-1) is the first discovered human oncogenic retrovirus that can cause adult T-cell leukemia/lymphoma, HTLV-1-as...
Accurate disease prognosis is essential for patient care but is often hindered by the scarcity of longitudinal data. This study explores deep learning...
BACKGROUND: Financial toxicity (FT), the economic stress from medical care, is common among people with cancer and is associated with worse health out...
CONTEXT.—: Advances in computer vision have fueled the development of artificial intelligence (AI)-based algorithms for pathology. AI-assisted approac...
Objective This study aimed to investigate whether artificial intelligence could identify pancreatic ductal adenocarcinoma (PDAC) in patients aged <70 ...
Focused ultrasound (FUS) is an emerging therapeutic and diagnostic technology in neuro-oncology, offering new strategies for molecular diagnosis, drug...
Extracellular vesicles (EVs) have emerged as promising biomarkers for liquid biopsy. However, their clinical detection is hampered by heterogeneity an...
Preclinical immunotherapy research relies heavily on animal tumor models, which can be broadly classified into four categories: genetically engineered...
Cervical cancer remains a major global health challenge, where dysregulated JAK2 signaling constitutes a key molecular driver. Nevertheless, selective...
Analysis of tumors using single-cell and spatial modalities is critical to advance our understanding of cancer. The growth of technologies that enable...